Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000644823 | SCV000766538 | likely benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2023-10-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004025671 | SCV004948667 | uncertain significance | Inborn genetic diseases | 2024-01-16 | criteria provided, single submitter | clinical testing | The c.2404A>G (p.S802G) alteration is located in exon 10 (coding exon 8) of the SETX gene. This alteration results from a A to G substitution at nucleotide position 2404, causing the serine (S) at amino acid position 802 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV004533373 | SCV004708419 | uncertain significance | SETX-related disorder | 2024-02-01 | no assertion criteria provided | clinical testing | The SETX c.2404A>G variant is predicted to result in the amino acid substitution p.Ser802Gly. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0023% of alleles in individuals of European (Non-Finnish) descent in gnomAD . At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |